Ezetimibe, Simvastatin Drug Combination
"Ezetimibe, Simvastatin Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pharmaceutical preparation of ezetimibe and simvastatin that is used in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.
| Descriptor ID |
D000069499
|
| MeSH Number(s) |
D02.455.426.559.847.638.400.900.500 D03.383.082.301.550.500 D04.615.638.400.900.500 D26.310.431
|
| Concept/Terms |
Ezetimibe, Simvastatin Drug Combination- Ezetimibe, Simvastatin Drug Combination
- Ezetimibe-Simvastatin Combination
- Combination, Ezetimibe-Simvastatin
- Ezetimibe Simvastatin Combination
- Ezetimibe Simvastatin Drug Combination
- Ezetimibe-Simvastatin Drug Combination
- Combination, Ezetimibe-Simvastatin Drug
- Drug Combination, Ezetimibe-Simvastatin
|
Below are MeSH descriptors whose meaning is more general than "Ezetimibe, Simvastatin Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Ezetimibe, Simvastatin Drug Combination".
This graph shows the total number of publications written about "Ezetimibe, Simvastatin Drug Combination" by people in this website by year, and whether "Ezetimibe, Simvastatin Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ezetimibe, Simvastatin Drug Combination" by people in Profiles.
-
Identical LDL-cholesterol lowering but non-identical effects on NF-?B activity: High dose simvastatin vs combination therapy with ezetimibe. Atherosclerosis. 2012 Jul; 223(1):190-6.
-
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category. Metab Syndr Relat Disord. 2009 Dec; 7(6):601-10.
-
Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. Am J Cardiol. 2007 Jun 15; 99(12):1706-1713.
-
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. Curr Med Res Opin. 2006 Oct; 22(10):2041-53.
-
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination. Vasc Health Risk Manag. 2006; 2(1):31-8.